GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » ATAI Life Sciences NV (MEX:ATAI) » Definitions » Machinery, Furniture, Equipment

ATAI Life Sciences NV (MEX:ATAI) Machinery, Furniture, Equipment : MXN0.00 Mil (As of Mar. 2024)


View and export this data going back to 2022. Start your Free Trial

What is ATAI Life Sciences NV Machinery, Furniture, Equipment?

ATAI Life Sciences NV's Machinery, Furniture, Equipment for the quarter that ended in Mar. 2024 was MXN0.00 Mil.


ATAI Life Sciences NV Machinery, Furniture, Equipment Historical Data

The historical data trend for ATAI Life Sciences NV's Machinery, Furniture, Equipment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

ATAI Life Sciences NV Machinery, Furniture, Equipment Chart

ATAI Life Sciences NV Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
Machinery, Furniture, Equipment
0.51 - - - -

ATAI Life Sciences NV Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Machinery, Furniture, Equipment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

ATAI Life Sciences NV Machinery, Furniture, Equipment Calculation

Machinery, Furniture, Equipment represents those fixed assets specifically dealing with tools, equipment and office furniture.


ATAI Life Sciences NV (MEX:ATAI) Business Description

Industry
Traded in Other Exchanges
Address
Wallstraße 16, Berlin, BB, DEU, 10179
ATAI Life Sciences NV is a clinical-stage biopharmaceutical company aiming to transform the treatment of mental health disorders. Its product candidates include COMP360/Psilocybin therapy, PCN-101/R-ketamine, RL-007/Compound, DMX-1002/Ibogaine, GRX-917/Deuterated etifoxine, VLS-01/DMT, EMP-01/MDMA derivative, RLS-01/Salvinorin A, KUR-101/Deuterated Mitragynine, and DMX-1001/Noribogaine. The business operates geographically in two regions being the United States and Germany.

ATAI Life Sciences NV (MEX:ATAI) Headlines

From GuruFocus

Women in Psychedelics Announces atai as Platinum Sponsors

By Business Wire Business Wire 11-04-2022

atai Life Sciences to Participate in Upcoming May Investor Conference

By sperokesalga sperokesalga 05-02-2023